📂 Category
Medicine shortage
Across channels:
💊 Medical · 640
Medium risk
🇪🇺
resolved
Respreeza
INN: alpha1-proteinase inhibitor (human) · Forms: Powder and solvent for solution for infusion · Strengths: 1,000 mg ;4,000 mg ;5,000 mg · Area: Genetic Disease…
5 years ago
See more →
Medium risk
🇪🇺
resolved
Nucala
INN: mepolizumab · Forms: Pre-filled pen · Strengths: 40 mg ;100 mg · Area: Asthma · Alternatives: Yes
5 years ago
See more →
Medium risk
🇪🇺
resolved
Zerbaxa
INN: ceftolozane;tazobactam · Forms: Concentrate for solution for infusion · Strengths: 1 g;0.5 g · Area: Bacterial Infections · Alternatives: Yes
5 years ago
See more →
Serious risk
🇦🇹
resolved
Dobutamin "Pharmaselect" 250 mg - Infusionslösung 250 mg (Infusionslösung)
Dobutamine "Pharmaselect" 250 mg infusion solution is currently unavailable due to a parallel export ban. Supply is expected to resume on December 31, 2027.
5 years ago
See more →
Serious risk
🇦🇹
resolved
Dobutamin "Pharmaselect" 500 mg - Infusionslösung (Infusionslösung)
Dobutamine "Pharmaselect" 500 mg infusion solution is banned from parallel export.
5 years ago
See more →
Low risk
🇦🇹
resolved
Octagam 100 mg/ml Infusionslösung 100 mg/ml (Infusionslösung)
Octagam 100 mg/ml infusion solution is subject to a parallel export ban due to active ingredient shortages. Supply for domestic patients cannot be met despite n…
5 years ago
See more →
Low risk
🇦🇹
resolved
Octagam 5% Infusionslösung 5 % (Infusionslösung)
Export of this medicine is restricted due to limited supply. Supplies are reserved for domestic patients. Do not attempt to obtain or distribute this product ou…
5 years ago
See more →
Low risk
🇦🇹
resolved
GAMMAGARD S/D Pulver und Lösungsmittel zur Herstellung einer Infusionslösung (Pulver und Lösungsmittel zur Herstellung einer Infusionslösung)
Gammagard S/D powder and solvent for infusion solution (powder and solvent for preparing an infusion solution) is subject to a parallel export ban.
5 years ago
See more →
Low risk
🇦🇹
resolved
Cuvitru 200 mg/ml Injektionslösung zur subkutanen Anwendung 200 mg/ml (Injektionslösung)
Cuvitru 200 mg/ml injection solution for subcutaneous use is subject to a parallel export ban due to active ingredient shortages.
5 years ago
See more →
Low risk
🇦🇹
resolved
Intratect 100 g/l Infusionslösung 100 g/l (Infusionslösung)
Parallel export of Intratect 100 g/l infusion solution is banned due to active ingredient shortages. The medicine is authorised by Biotest Pharma GmbH in German…
5 years ago
See more →
Low risk
🇦🇹
resolved
Intratect 50 g/l Infusionslösung 50 g/l (Infusionslösung)
Parallel export ban in effect for Intratect 50 g/l infusion solution due to active ingredient shortage.
5 years ago
See more →
Low risk
🇦🇹
resolved
Ig Vena 50 g/l Infusionslösung 50 g/l (Infusionslösung)
Parallel export ban active for Ig Vena 50 g/l Infusionslösung.
5 years ago
See more →
Low risk
🇦🇹
resolved
HyQvia 100 mg/ml Infusionslösung zur subkutanen Anwendung 100 mg/ml (Infusionslösung)
HyQvia 100 mg/ml infusion solution for subcutaneous use is subject to a parallel export ban due to active ingredient shortages.
5 years ago
See more →
Low risk
🇦🇹
resolved
Privigen 100 mg/ml Infusionslösung 100 mg/ml (Infusionslösung)
Parallel export ban active for Privigen 100 mg/ml infusion solution. Supply is limited due to active ingredient shortage. Patient needs within Germany cannot be…
5 years ago
See more →
Low risk
🇦🇹
resolved
KIOVIG 100 mg/ml Infusionslösung (Infusionslösung)
Parallel export of KIOVIG 100 mg/ml infusion solution is banned due to active ingredient shortages. The product is not available for domestic patient needs desp…
5 years ago
See more →
Medium risk
🇦🇹
resolved
Visudyne 15 mg Pulver zur Herstellung einer Infusionslösung (Pulver zur Herstellung einer Infusionslösung)
Parallel export ban in effect. Supply limited due to manufacturing capacity issues. Affected packs: one vial, restricted since July 31, 2020, with resupply expe…
5 years ago
See more →
Serious risk
🇦🇹
resolved
Lactat - oral "Wabo" flüssig (Lösung zum Einnehmen)
Lactat oral "Wabo" liquid (solution for ingestion) is banned from parallel export. It is no longer available since 26 May 2020.
6 years ago
See more →
Serious risk
🇪🇺
Visudyne
INN: verteporfin · Forms: Powder for solution for infusion · Strengths: 15 mg · Area: Myopia, Degenerative;Macular Degeneration · Alternatives: Yes
6 years ago
See more →
Serious risk
🇦🇹
resolved
Instillagel - Einmalspritze (Gel, Gel zur Anwendung in der Harnröhre)
Instagel single-use syringe (gel for urethral use) is subject to a parallel export ban. Supplies are delayed due to compliance with anti-counterfeiting regulati…
6 years ago
See more →
Serious risk
🇦🇹
resolved
Lanitop 0,2 mg - Ampullen (Injektionslösung)
Lanitop 0.2 mg ampoules (injection solution) are subject to a parallel export ban.
6 years ago
See more →
Serious risk
🇦🇹
resolved
Neurolepsin - Tabletten (Tablette)
Neurolepsin tablets are unavailable due to manufacturing non-compliance.
6 years ago
See more →
Serious risk
🇦🇹
resolved
Halomycetin - Augensalbe (Augensalbe)
Halomycetin eye ointment is unavailable.
6 years ago
See more →
Medium risk
🇪🇺
resolved
Cinryze
INN: C1 inhibitor (human) · Forms: Powder and solvent for intravenous injection · Strengths: 500 IU · Area: Angioedemas, Hereditary · Alternatives: Yes
7 years ago
See more →
Serious risk
🇦🇹
resolved
Vicard 1 mg - Tabletten (Tablette)
Vicard 1 mg tablets are delayed in production.
8 years ago
See more →
Serious risk
🇦🇹
resolved
Timoftal 0,25 % - Augentropfen
Timoftal 0.25% eye drops are temporarily unavailable.
8 years ago
See more →
Medium risk
🇪🇺
resolved
Trisenox
INN: arsenic trioxide · Forms: Solution for infusion · Area: Leukemia, Promyelocytic, Acute · Alternatives: Yes
8 years ago
See more →
Medium risk
🇪🇺
resolved
Arixtra
INN: fondaparinux sodium · Forms: Pre-filled syringe · Strengths: 1.5 mg;2.5 mg;5.0 mg;7.5 mg · Area: Venous Thrombosis;Pulmonary Embolism;Myocardial Infarction…
8 years ago
See more →
Medium risk
🇪🇺
resolved
Nulojix
INN: belatacept · Forms: Solution for infusion · Strengths: 25 mg/ml · Area: Graft Rejection;Kidney Transplantation
9 years ago
See more →
Medium risk
🇪🇺
resolved
Orgalutran
INN: ganirelix · Forms: Solution for injection in pre-filled pen · Strengths: 0.25 mg/0.5 ml · Area: Reproductive Techniques, Assisted;Ovulation Induction;Infer…
9 years ago
See more →
Medium risk
🇪🇺
resolved
Taxotere
INN: docetaxel · Forms: Concentrate for solution for infusion · Strengths: 20 mg;1 ml and 80g;4 ml · Area: Head and Neck Neoplasms;Carcinoma, Non-Small-Cell Lun…
10 years ago
See more →
Serious risk
🇪🇺
Insuman Basal and Comb 25
INN: insulin human · Forms: Catridge;Pre-filled pen · Strengths: 3 ml · Area: Diabetes Mellitus · Alternatives: Yes
10 years ago
See more →
Medium risk
🇪🇺
resolved
Inductos
INN: dibotermin alfa · Forms: Powder, solvent and matrix for implantation matrix · Area: Tibial Fractures;Fracture Fixation, Internal;Spinal Fusion · Alternativ…
10 years ago
See more →
Medium risk
🇪🇺
resolved
Tygacil
INN: tigecycline · Forms: Powder for solution for infusion · Area: Bacterial Infections;Skin Diseases, Bacterial;Soft Tissue Infections · Alternatives: Yes
11 years ago
See more →
Medium risk
🇪🇺
resolved
Insuman Rapid, Basal and Comb
INN: insulin human · Forms: Catridge;Pre-filled pen · Strengths: 3 ml · Area: Diabetes Mellitus · Alternatives: Yes
11 years ago
See more →
Medium risk
🇪🇺
resolved
Xofigo
INN: radium Ra223 dichloride · Forms: Solution for injection · Strengths: 1100 kBq/ml · Area: Prostatic Neoplasms · Alternatives: No
11 years ago
See more →
Medium risk
🇪🇺
resolved
Buccolam
INN: midazolam · Forms: Pre-filled syringe · Strengths: 2.5 mg;5 mg;7.5 mg;10 mg · Area: Epilepsy · Alternatives: Not stated
12 years ago
See more →
Medium risk
🇪🇺
resolved
Enbrel
INN: etanercept · Forms: Pre-filled syringe;Pre-filled pen · Strengths: 10 mg;25 mg;50 mg · Area: Spondylitis, Ankylosing;Arthritis, Juvenile Rheumatoid;Arthrit…
12 years ago
See more →
Medium risk
🇪🇺
resolved
Increlex
INN: mecasermin · Forms: Solution for subcutaneous injection · Strengths: 10 mg/ml · Area: Laron Syndrome · Alternatives: No
12 years ago
See more →
Medium risk
🇪🇺
resolved
Fabrazyme
INN: agalsidase beta · Forms: Powder for concentrate for solution for infusion · Strengths: 5 mg;35 mg · Area: Fabry Disease · Alternatives: No
12 years ago
See more →
Other categories
Other
(19,552)
Fruits & vegetables
(9,356)
Processed foods
(9,038)
Feed & pet food
(7,037)
Toys
(6,439)
Meat & poultry
(5,884)
Cosmetics
(5,391)
Motor vehicles
(4,776)
Nuts & seeds
(4,742)
Electrical & lighting
(4,304)
Fish & seafood
(4,137)
Cereals & bakery
(2,886)
Herbs & spices
(2,647)
Confectionery & sweets
(2,587)
Clothing & textiles
(2,461)
Dairy & eggs
(1,899)
Beverages
(1,787)
Food-contact materials
(1,704)
Jewellery
(1,033)
Childcare articles
(964)
Protective equipment
(747)
Sports & hobby
(656)
Machinery
(578)
Furniture & decor
(422)
Pyrotechnic & lighters
(410)
Kitchen & cooking
(168)